In the randomized HAELO trial, the novel in vivo CRISPR-based therapy lonvoguran ziclumeran (lonvo-z) dramatically reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results